Zettlitz, Kirstin A. http://orcid.org/0000-0003-4870-6603
Tavaré, Richard
Tsai, Wen-Ting K.
Yamada, Reiko E.
Ha, Noel S.
Collins, Jeffrey
van Dam, R. Michael
Timmerman, John M.
Wu, Anna M.
Funding for this research was provided by:
National Institutes of Health (CA149254, CA212718, CA016042)
Article History
Received: 6 August 2018
Accepted: 4 November 2018
First Online: 19 November 2018
Compliance with ethical standards
:
: JM Timmerman reports receiving commercial research grants from Bristol-Myers Squibb, Kite Pharma, and Valor Biotherapeutics, and is a consultant/ advisory board member for Celgene and Seattle Genetics. AM Wu holds ownership interest in and is a consultant/advisory board member for ImaginAb, Inc. No potential conflicts of interest were disclosed by the other authors.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the University of California Los Angeles (UCLA) Animal Research Committee. This article does not contain any studies with human participants performed by any of the authors.